Massively parallel in vivo biologics discovery
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $45.4M
Investors 7
| Date | Name | Website |
| - | Fifty Year... | fiftyyears... |
| - | FAST — by ... | fast.xyz |
| - | FPV Ventur... | fpvventure... |
| - | S32 | s32.com |
| - | Playground... | playground... |
| 09.09.2020 | Playground... | playground... |
| - | Tencent | tenx.tc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.07.2022 | Series A | $40M | Horizons V... |
| 08.09.2020 | Seed | $5.4M | - |
Mentions in press and media 12
| Date | Title | Description |
| 31.10.2025 | Названы самые перспективные стартапы мира. «Инк» узнал что они создают | Всему миру известны компании, некоторые из которых стартовали из гаража или студенческой комнаты. С развитием искусственного интеллекта тысячи стартапов регулярно борются за место под солнцем (и за инвестиции). Одна из возможностей получить... |
| 14.07.2022 | Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck | In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio’s molecular machinery could let a hundred mo... |
| 14.07.2022 | Back in the Manifold: George Church-founded protein therapeutics biotech tacks on $40M in series A funds | Almost two years after launching, George Church-founded Manifold Bio has raised a $40 million series A to continue development of its protein barcode system and advance a number of oncology programs. The latest haul, announced Thursday, wil... |
| 14.07.2022 | George Church startup Manifold Bio raises $40M for ‘protein barcoding’ technology to improve drug testing | Manifold Bio, a new startup founded by one of Boston’s most prolific biotech entrepreneurs, has raised $40 million to develop a technology that could make testing cancer drugs more efficient. The company is designing a system for “barcoding... |
| 14.07.2022 | Manifold Bio Raises $40M in Series A Funding | Manifold Bio, a Boston, MA-based protein therapeutics company, raised $40M in Series A funding. The round was led by Triatomic Capital with participation from Section 32, FPV Ventures, Horizons Ventures, Tencent, Playground Global, Fifty Ye... |
| 14.07.2022 | Manifold Bio Closes $40M Series A Round | BOSTON, MA, Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing round. >> Click here for more funding data on M... |
| 11.09.2020 | Startups To Watch: Manifold Bio, Writer.com, Infinite Looks | 17 Shares Email Facebook Twitter LinkedIn Crunchbase News typically covers larger funding rounds, however we think these startups are worth highlighting for their interesting approaches despite their smaller raises. Subscribe to the Crunchb... |
| 11.09.2020 | Startups To Watch: Manifold Bio, Writer.com, Infinite Looks | 16 Shares Email Facebook Twitter LinkedIn Crunchbase News typically covers larger funding rounds, however we think these startups are worth highlighting for their interesting approaches despite their smaller raises. Subscribe to the Crunchb... |
| 10.09.2020 | Manifold Bio Raises $5.4M Seed Round | BOSTON, MA, Manifold Bio announced today the close of a $5.4 million Series Seed investment round, led by Playground Global. >> Click here for more funding data on Manifold Bio >> To export Manifold Bio funding data to PDF a... |
| 08.09.2020 | Could protein barcodes speed up drug development? Manifold Bio scores $5.4M to find out | - |
Show more